To recover your password please fill in your email address
Please fill in below form to create an account with us
Title: Single arm, open label signal seeking, phase II trial to study the clinical activity of Tildrakizumab in patients with advanced osteosarcoma and soft tissue sarcomas.
The aim of these MoST substudies is to assess the clinical activity of tildrakizumab in patients with advanced osteosarcomas or soft tissue sarcomas.
Treatment-refractory advanced osteosarcoma and other sarcomas.
Prof David Thomas